BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports - 2The Ursid meteor shower will be the last of the year, peaking just before Christmas: What to know and how to watch
- 3Andrew McCarthy's awe-inspiring image of a skydiver in front of the sun
- 4Space Condos to Lift Your Metropolitan Living
- 5Dad issues urgent plea to find stem cell donor for his son
- Air superiority and long-range strikes: what China's war games say about how it might assault Taiwan
- New method spots signs of Earth's primordial life in ancient rocks
- The most effective method to Guarantee Thorough Inclusion in Senior Protection.
- Tyler Childers' 'Snipe Hunt' 2026 Tour: How to get tickets, presale times, prices and more
- Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- Two UN peacekeepers killed in explosion in Lebanon
- Audits of Espresso Types: Which Mix Is for You?
- Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home
- Seoul says sorry after unapproved drone flights into North Korea
